Engineering single-cycle MeV vector for CRISPR-Cas9 gene editing is a research paper published in Molecular Therapy β Methods & Clinical Development (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL147852
NHLBI NIH HHS
Grant: R56 HL147852
National Institutes of Health
Grant: 1R56HL147852-01
Single non-integrating RNA vector for gene editing and reprogramming of Fanconi anemia fibroblasts
NHLBI
Regenerative Medicine Minnesota
FWCI
0.16
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals